Identify Assets & Mechanisms
From Clinical Evidence to Strategic Opportunity Intelligence
MASH Intelligence Platform
Navigate the Healthcare Marketplace Landscape
Navigate the evolving MASH landscape with integrated asset intelligence, clinical evidence, mechanism analysis and competitive opportunity assessment.
The SPER MASH Intelligence Platform helps pharmaceutical and biotechnology organisations understand the competitive landscape,
evaluate therapeutic assets and identify opportunities for differentiation.
Core Capabilities
Comprehensive MASH Intelligence Framework
Integrated asset intelligence, clinical evidence analysis, mechanism assessment and competitive opportunity evaluation to support strategic decision-making.
Asset & Clinical Intelligence
Track MASH assets, clinical trials, development phases, endpoints, efficacy, safety and key milestones across the landscape.
Mechanism & Target Intelligence
Assess therapeutic mechanisms, clinical validation and emerging areas of scientific interest in MASH treatments.
Competitive Benchmarking
Compare assets across clinical evidence, development maturity and potential differentiation strategies.
Opportunity Scoring
Evaluate profiled assets across five weighted criteria: Maturity, Clinical Evidence, Competitive Headroom, Segment Breadth and Delivery Fit.
Regulatory & Strategic Intelligence
Monitor regulatory developments, clinical readouts, partnerships, licensing and M&A activities in MASH space.
Primary Market Intelligence & KOL Atlas
Combine structured expert research with AI-based KOL mapping to investigate treatment perceptions and adoption barriers.
Find experts instantly with specialty, geography, publication volume, trial involvement, and semantic similarity search powered by OpenSearch + pgvector.
Scientific Intelligence
Track KOL evolution: new publications, trials, affiliation shifts, emerging experts, collaboration clusters, and scientific momentum.
Enterprise Security
GDPR-aligned, HIPAA-aware workflows, ISO-aligned security, role-based access, audit logs, and global compliance support.
Network Visualization
Visualize co-authorship, institutional relationships, referral pathways, and influence networks to uncover hidden opportunities.
From Intelligence to Decisions
Connect Evidence, Competition & Opportunity
Investigate White Spaces
Monitor Differentiation
Support Prioritization
Assess Combinations
Strategic Decisions
Connected Intelligence
"Clinical evidence. Competitive insight. Strategic clarity."
The MASH Intelligence Platform integrates clinical evidence, mechanism intelligence, competitive benchmarking and opportunity assessment. Our AI-powered analytics help pharma and biotech organizations evaluate therapeutic assets and identify differentiation opportunities in an increasingly complex MASH landscape. Move beyond tracking to understanding the strategic implications.
Explore MASH Intelligence Platform →
Platform Features
Key Capabilities For Strategic Decision-Making
Pharmaceutical and biotech teams use MASH Intelligence to navigate asset development, assess competitive positioning, and prioritize opportunities.
Global KOL Database
1 million+ KOLs mapped across major therapeutic areas, institutions, and global markets.
Automated Data Ingestion
APIs + institutional sources for seamless data integration.
AI Cleaned Structured Data
High quality, validated, deduplicated data for reliable insights.
Real Time Updates
Daily/weekly deltas with change logs to stay current.
Deep Analytics
Trends, clusters, networks, influence scoring for strategic decisions.
Custom Dashboards
Tailored views for medical, clinical, and commercial teams.
KOL Planning
Support territory planning, launch readiness, segmentation, and engagement prioritization.
KOL Interactions
Capture, organize, and analyze engagement history, touchpoints, and field insights.
Compliance & Policy Support
Enable governance aligned workflows with auditability, access controls, and policy-aware data handling.
Advanced Analytics
Track trends, segment experts, compare markets, and uncover strategic patterns across the KOL landscape.
Network Visualization
Visualize co-authorship, institutional relationships, referral pathways, and influence networks.
Competitive Intelligence
Monitor competitor-linked experts, shifting affiliations, emerging voices, and whitespace opportunities.
Research Hub
Centralize publications, trials, abstracts, congress activity, and scientific outputs in one workspace.
FMV & Compensation
Support fair market value reviews and compensation planning with structured expert profile context.
Configurable Scoring Weights
Customize ranking models using weighted criteria such as publications, trials, influence, geography, and strategic fit.
Get Started
Ready to accelerate MASH strategy and discovery?
Experience how MASH Intelligence Platform helps pharmaceutical and biotech teams navigate asset development, assess competitive positioning, and identify differentiation opportunities.
Request a DemoFAQ
Frequently Asked Questions
Everything you need to know about MASH Intelligence Platform before getting started.
MASH Intelligence Platform is a comprehensive research solution designed for pharmaceutical and biotechnology organizations navigating the evolving MASH landscape. The platform integrates asset intelligence, clinical evidence analysis, mechanism assessment and competitive opportunity evaluation. It helps medical affairs, business development, and clinical strategy teams understand the competitive landscape, evaluate therapeutic assets, identify differentiation opportunities, and make data-driven strategic decisions in MASH development and commercialization.
MASH Intelligence Platform delivers six core capabilities: Asset & Clinical Intelligence to track MASH assets, trials, and milestones; Mechanism & Target Intelligence to assess therapeutic mechanisms and clinical validation; Competitive Benchmarking to compare assets across clinical evidence and development maturity; Opportunity Scoring using five weighted criteria; Regulatory & Strategic Intelligence to monitor developments and partnerships; and Primary Market Intelligence & KOL Atlas integration to combine expert research with AI-based KOL mapping for treatment perceptions and adoption barrier analysis.
MASH Intelligence Platform evaluates profiled assets across five weighted criteria: Maturity (development stage and clinical validation), Clinical Evidence (efficacy, safety, and endpoint strength), Competitive Headroom (differentiation potential), Segment Breadth (patient population and market size), and Delivery Fit (commercial viability). This framework supports structured prioritization and enables teams to explore Base, Evidence-led, and Headroom-led scenarios for strategic decision-making and portfolio assessment.
MASH Intelligence Platform provides 360° Competitive Landscape View through integrated asset intelligence, clinical evidence analysis, and mechanism assessment. The platform tracks regulatory developments, clinical readouts, partnerships, licensing and M&A activities. It enables competitive benchmarking across clinical evidence, development maturity, and differentiation strategies, helping teams understand competitive positioning and identify white space opportunities for strategic differentiation.
MASH Intelligence Platform is used by medical affairs, business development, clinical strategy, and competitive intelligence teams. Organizations leverage the platform to navigate asset development, assess competitive positioning, prioritize portfolio opportunities, support launch strategies, evaluate combination therapies, and make data-driven strategic decisions. The platform enables teams to move beyond tracking to understanding strategic implications and identifying emerging opportunities in the MASH landscape.
Getting started is simple. Request a personalized demo and our team will provide a tailored walkthrough based on your strategic priorities—whether asset development assessment, competitive positioning analysis, or opportunity identification. We'll demonstrate how clinical evidence, mechanism intelligence, and competitive benchmarking combine to support better-informed strategic decisions and accelerate your MASH strategy.
